Serum Concentration of IL-5 Receptor (IL-5R) and Associations with Disease Severity in Patients with Chronic Spontaneous Urticaria (CSU) and Atopic Dermatitis (AD)

• Published in: International journal of molecular sciences 2024-07, Vol.25 (14), p.7598
• Main Authors: Gomułka, Krzysztof, Tota, Maciej, Laska, Julia, Gojny, Karina, Sędek, Łukasz
• Format: Article
• Language: English
• Subjects: Adult; atopic dermatitis; Biomarkers - blood; Case-Control Studies; chronic spontaneous urticaria; Chronic Urticaria - blood; Cytokines; Dermatitis; Dermatitis, Atopic - blood; Female; Haplotypes; Histamine; Humans; Inflammation; interleukin-5; interleukin-5 receptor; Interleukin-5 Receptor alpha Subunit; Male; Middle Aged; Pathogenesis; Pilot Projects; Pruritus - blood; Receptors, Interleukin-5 - blood; SCORAD index; Severity of Illness Index; UAS7 scale; Urticaria; Young Adult
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25147598

The immunological pathogenesis of atopic dermatitis (AD) and chronic spontaneous urticaria (CSU) has not been fully elucidated yet. The aim of our research was to assess the serum concentration of interleukin-5 receptor (IL-5R) in relation to the disease activity and pruritus intensity in adult patients with AD and CSU. This pilot study included 45 participants (15 patients with AD, 15 patients with CSU, and 15 healthy controls). Blood samples were taken to examine the serum levels of IL-5R using the enzyme-linked immunosorbent assay (ELISA) test. The Scoring Atopic Dermatitis (SCORAD) index, the Urticaria Activity Score (UAS7), and the Visual Analogue Scale (VAS) were used to assess the disease activity and the pruritus intensity, respectively. Obtained results revealed that the IL-5R concentration was significantly higher in patients with CSU than in patients with AD and in the controls ( = 0.038). There was a positive correlation between the IL-5R level and the SCORAD index in patients with AD (r = -0.9, = 0.047), which was not found for the CSU activity by UAS7 and with the pruritus severity by VAS in both examined groups of patients. Our findings underscore higher serum levels of IL-5R among CSU and AD patients, which may highlight its functional role in the pathogenesis of these diseases. In contrast, IL-5R might not be fully useful in reflecting the severity of symptoms. Although our results are promising, this study should be conducted on a larger cohort of patients.